ABBV vs TMO: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$658.32
+31.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+31.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
TMO |
| Current Price |
$261.70 |
$658.32 |
| Fair Value Estimate |
$259.04 |
$863.34 |
| Upside to Fair Value |
-1.0%
|
+31.1%
|
| Market Cap |
$462.4B |
$244.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
25.9x
|
| Price / Sales |
7.2x
|
5.3x
|
| Price / FCF |
23.6x
|
33.4x
|
| Revenue Growth YoY |
+10.2%
|
+10.5%
|
| Gross Margin |
71.5%
|
40.4%
|
| Operating Margin |
29.3%
|
17.7%
|
| Return on Equity |
-136.5%
|
13.4%
|
| Dividend Yield |
2.61% |
0.28% |
| FCF Yield |
4.25%
|
3.0%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Thermo Fisher Scientific is a global life-sciences and laboratory-services platform spanning Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, with recognized brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD, serving pharmaceutical, biotech, clinical, academic, and governme…
Accumulation Zones
| Metric |
ABBV |
TMO |
| Zone Low |
$194.28 |
$647.50 |
| Zone High |
$220.18 |
$733.84 |
| In Buy Zone? |
No
|
Yes
|